Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

EULAR recommendations for the management of antiphospholipid syndrome in adults.

Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM.

Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213. Epub 2019 May 15.

PMID:
31092409
2.

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Marozio L, Espinosa G, Cervera R, Ríos-Garcés R, De Carolis S, Latino O, LLurba E, Chighizola CB, Gerosa M, Pengo V, Lundelin K, Rovere-Querini P, Canti V, Mayer-Pickel K, Reshetnyak T, Hoxha A, Tabacco S, Stojanovich L, Gogou V, Varoudis A, Arnau A, Ruiz-Hidalgo D, Trapé J, Sos L, Stoppani C, Martí-Cañamares A, Farran-Codina I; EUROAPS Study Group.

Autoimmun Rev. 2019 Apr;18(4):406-414. doi: 10.1016/j.autrev.2018.12.006. Epub 2019 Feb 15.

PMID:
30772493
3.

Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.

Pérez D, Stojanovich L, Naranjo L, Stanisavljevic N, Bogdanovic G, Serrano M, Serrano A.

Front Immunol. 2018 Nov 20;9:2644. doi: 10.3389/fimmu.2018.02644. eCollection 2018.

4.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL.

Autoimmun Rev. 2018 Dec;17(12):1153-1168. doi: 10.1016/j.autrev.2018.05.012. Epub 2018 Oct 12. Review.

PMID:
30316994
5.

Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.

Bećarević M, Sarić M, Stojanovich L, Mirković D, Dopsaj V, Ignjatović S.

Clin Rheumatol. 2018 Dec;37(12):3359-3364. doi: 10.1007/s10067-018-4170-7. Epub 2018 Jun 12.

PMID:
29948348
6.

Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?

Belizna C, Stojanovich L, Cohen-Tervaert JW, Fassot C, Henrion D, Loufrani L, Nagy G, Muchardt C, Hasan M, Ungeheuer MN, Arnaud L, Alijotas-Reig J, Esteve-Valverde E, Nicoletti F, Saulnier P, Godon A, Reynier P, Chrétien JM, Damian L, Omarjee L, Mahé G, Pistorius MA, Meroni PL, Devreese K.

Autoimmun Rev. 2018 Aug;17(8):739-745. doi: 10.1016/j.autrev.2018.01.027. Epub 2018 Jun 6. Review.

7.

Relationship between cerebrovascular and valvular manifestations in a Serbian cohort of patients with antiphospholipid syndrome.

Djokovic A, Stojanovich L, Stanisavljevic N, Banicevic S, Smiljanic D, Milovanovic B.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):850-855. Epub 2018 May 24.

PMID:
29846156
8.

The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome.

Stojanovich L, Djokovic A, Stanisavljevic N, Zdravkovic M.

Lupus. 2018 Apr;27(5):858-863. doi: 10.1177/0961203317751065. Epub 2018 Jan 4.

PMID:
29301476
9.

Abdominal pain in patient with antiphospholipid syndrome-the role of MDCT angiography on visceral blood vessels.

Saponjski J, Stojanovich L, Saponjski J, Mirilovic M, Saponjski D.

Immunol Res. 2017 Dec;65(6):1150-1155. doi: 10.1007/s12026-017-8968-1.

PMID:
29134567
10.

Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling.

Kapadia M, Bijelić D, Zhao H, Ma D, Stojanovich L, Milošević M, Andjus P, Šakić B.

Acta Neuropathol Commun. 2017 Sep 7;5(1):70. doi: 10.1186/s40478-017-0473-1.

11.

The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.

Agmon-Levin N, Dagan A, Peri Y, Anaya JM, Selmi C, Tincani A, Bizzaro N, Stojanovich L, Damoiseaux J, Cohen Tervaert JW, Mosca M, Cervera R, Shoenfeld Y.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):929-935. Epub 2017 Jul 6.

PMID:
28770708
12.

Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations?

Kontic M, Stojanovich L, Mijailović-Ivković M, Velinović M, Srnka J, Zdravkovic M.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):56-61. Epub 2017 Jul 17.

PMID:
28770705
13.

The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome.

Saponjski J, Stojanovich L, Petrovic J, Saponjski D.

Immunol Res. 2017 Apr;65(2):482-486. doi: 10.1007/s12026-016-8887-6.

PMID:
28124228
14.

Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.

Stanisavljevic N, Stojanovich L, Marisavljevic D, Djokovic A, Dopsaj V, Kotur-Stevuljevic J, Martinovic J, Memon L, Radovanovic S, Todic B, Lisulov D.

Clin Rheumatol. 2016 Oct;35(10):2485-93. doi: 10.1007/s10067-016-3369-8. Epub 2016 Aug 25.

PMID:
27562033
15.

Physical Activity Program Is Helpful for Improving Quality of Life in Patients with Systemic Lupus Erythematosus.

Bogdanovic G, Stojanovich L, Djokovic A, Stanisavljevic N.

Tohoku J Exp Med. 2015 Nov;237(3):193-9. doi: 10.1620/tjem.237.193.

16.

Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis.

Foltyn Zadura A, Memon AA, Stojanovich L, Perricone C, Conti F, Valesini G, Bogdanovic G, Hillarp A, Shoenfeld Y, Sundquist J, Leffler J, Svensson PJ, Trouw LA, Blom AM.

J Rheumatol. 2015 Oct;42(10):1786-93. doi: 10.3899/jrheum.150185. Epub 2015 Aug 15.

PMID:
26276971
17.
18.

Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.

Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Čučnik S.

Immunol Res. 2015 Feb;61(1-2):45. doi: 10.1007/s12026-014-8610-4. No abstract available.

PMID:
25480741
19.

Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.

Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Čučnik S.

Immunol Res. 2015 Feb;61(1-2):35-44. doi: 10.1007/s12026-014-8578-0. Erratum in: Immunol Res. 2015 Feb;61(1-2):45.

PMID:
25395339
20.

Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.

Djokovic A, Stojanovich L, Kontic M, Stanisavljevic N, Radovanovic S, Marisavljevic D.

Isr Med Assoc J. 2014 Mar;16(3):162-7.

21.

Tomography and blood vessels in Hughes syndrome.

Stojanovich L, Djokovic A.

Lupus. 2014 Apr;23(4):337-41. doi: 10.1177/0961203313520061. Epub 2014 Jan 16. Review.

PMID:
24436444
22.

Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome.

Leffler J, Stojanovich L, Shoenfeld Y, Bogdanovic G, Hesselstrand R, Blom AM.

Clin Exp Rheumatol. 2014 Jan-Feb;32(1):66-70. Epub 2013 Dec 2.

PMID:
24295292
23.

Does the presence of secondary antiphospholipid syndrome in patients with systemic lupus erythematodes accelerate carotid arteries intima-media thickness changes?

Djokovic A, Stojanovich Lj, Stanisavljevic N, Bisenic V, Radovanovic S, Soldatovic I, Simic DV.

Rheumatol Int. 2014 Mar;34(3):321-7. Epub 2013 Nov 15.

PMID:
24232505
24.

Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).

Agmon-Levin N, Rosário C, Katz BS, Zandman-Goddard G, Meroni P, Cervera R, Stojanovich L, Blank M, Pierangeli S, Praprotnik S, Meis Ed, Seguro LP, Ruffatti A, Pengo V, Tincani A, Doria A, Shoenfeld Y.

Lupus. 2013 Nov;22(13):1327-35. doi: 10.1177/0961203313504633. Epub 2013 Sep 13.

PMID:
24036580
25.

Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome.

Stojanovich L, Kontic M, Smiljanic D, Djokovic A, Stamenkovic B, Marisavljevic D.

Clin Exp Rheumatol. 2013 Sep-Oct;31(5):756-60. Epub 2013 Jul 30.

PMID:
23899875
26.

Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis.

Fischer S, Agmon-Levin N, Shapira Y, Porat Katz BS, Graell E, Cervera R, Stojanovich L, Gómez Puerta JA, Sanmartí R, Shoenfeld Y.

Immunol Res. 2013 Jul;56(2-3):287-92. doi: 10.1007/s12026-013-8402-2.

PMID:
23553228
27.

Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.

Stojanovich L, Kontic M, Djokovic A, Marisavljevic D, Ilijevski N, Stanisavljevic N, Mikovic Z, Petkovic M, Kovcin V.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):234-42. Epub 2013 Jan 7.

PMID:
23306109
28.

Influenza vaccination in autoimmune rheumatic disease patients.

Milanovic M, Stojanovich L, Djokovic A, Kontic M, Gvozdenovic E.

Tohoku J Exp Med. 2013 Jan;229(1):29-34.

29.

Helicobacter pylori serology in autoimmune diseases - fact or fiction?

Ram M, Barzilai O, Shapira Y, Anaya JM, Tincani A, Stojanovich L, Bombardieri S, Bizzaro N, Kivity S, Agmon Levin N, Shoenfeld Y.

Clin Chem Lab Med. 2013 May;51(5):1075-82. doi: 10.1515/cclm-2012-0477.

PMID:
23079514
30.

Prevalence of rubella serum antibody in autoimmune diseases.

Altman A, Szyper-Kravitz M, Agmon-Levin N, Gilburd B, Anaja JM, Barzilai O, Ram M, Bizzaro N, Stojanovich L, Damoiseaux J, Tervaert JW, Bombardieri S, Amital H, Shamis A, Shoenfeld Y.

Rev Bras Reumatol. 2012 May-Jun;52(3):307-18. English, Portuguese.

PMID:
22641586
31.

Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome.

Čučnik S, Kveder T, Artenjak A, Ulcova Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Alessandri C, Valesini G, Avčin T, Cohen Tervaert JW, Rozman B, Božič B.

Lupus. 2012 Jun;21(7):764-5. doi: 10.1177/0961203312440057.

PMID:
22635226
32.

Increased activity of interleukin-23/interleukin-17 cytokine axis in primary antiphospholipid syndrome.

Popovic-Kuzmanovic D, Novakovic I, Stojanovich L, Aksentijevich I, Zogovic N, Tovilovic G, Trajkovic V.

Immunobiology. 2013 Feb;218(2):186-91. doi: 10.1016/j.imbio.2012.03.002. Epub 2012 Mar 28.

PMID:
22559912
33.

Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.

Stojanovich L, Kontic M, Djokovic A, Ilijevski N, Stanisavljevic N, Marisavljevic D.

Scand J Rheumatol. 2012 May;41(3):223-6. doi: 10.3109/03009742.2011.641580. Epub 2012 Feb 13.

PMID:
22324785
34.

Gastrointestinal-associated autoantibodies in different autoimmune diseases.

Shor DB, Orbach H, Boaz M, Altman A, Anaya JM, Bizzaro N, Tincani A, Cervera R, Espinosa G, Stojanovich L, Rozman B, Bombardieri S, Vita SD, Damoiseaux J, Villalta D, Tonutti E, Tozzoli R, Barzilai O, Ram M, Blank M, Agmon-Levin N, Shoenfeld Y.

Am J Clin Exp Immunol. 2012 May 25;1(1):49-55. Print 2012.

35.

Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.

Stojanovich L, Markovic O, Marisavljevic D, Elezovic I, Ilijevski N, Stanisavljevic N.

Lupus. 2012 Mar;21(3):338-45. doi: 10.1177/0961203311422710. Epub 2011 Oct 12.

PMID:
21993381
36.

Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients.

Zandman-Goddard G, Orbach H, Agmon-Levin N, Boaz M, Amital H, Szekanecz Z, Szucs G, Rovensky J, Kiss E, Corocher N, Doria A, Stojanovich L, Ingegnoli F, Meroni PL, Rozman B, Gomez-Arbesu J, Blank M, Shoenfeld Y.

Clin Rev Allergy Immunol. 2013 Feb;44(1):23-30. doi: 10.1007/s12016-011-8264-0.

PMID:
21394428
37.

Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.

Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z, Szucs G, Rovensky J, Kiss E, Doria A, Ghirardello A, Gomez-Arbesu J, Stojanovich L, Ingegnoli F, Meroni PL, Rozman B, Blank M, Shoenfeld Y.

Clin Rev Allergy Immunol. 2012 Apr;42(2):189-98. doi: 10.1007/s12016-011-8256-0.

PMID:
21287295
38.

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.

van Assen S, Elkayam O, Agmon-Levin N, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M.

Autoimmun Rev. 2011 Apr;10(6):341-52. doi: 10.1016/j.autrev.2010.12.003. Epub 2010 Dec 20. Review.

PMID:
21182987
39.

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M.

Ann Rheum Dis. 2011 Mar;70(3):414-22. doi: 10.1136/ard.2010.137216. Epub 2010 Dec 3.

PMID:
21131643
40.

Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice?

Saponjski J, Stojanovich L, Djokovic A, Petkovic M, Mrda D.

Autoimmun Rev. 2011 Feb;10(4):235-7. doi: 10.1016/j.autrev.2010.11.002. Epub 2010 Nov 21. Review.

PMID:
21095242
41.

Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression.

Agmon-Levin N, Blank M, Zandman-Goddard G, Orbach H, Meroni PL, Tincani A, Doria A, Cervera R, Miesbach W, Stojanovich L, Barak V, Porat-Katz BS, Amital H, Shoenfeld Y.

Ann Rheum Dis. 2011 Jan;70(1):145-50. doi: 10.1136/ard.2010.134817. Epub 2010 Oct 27.

PMID:
20980705
42.

Prolactin's role in the pathogenesis of the antiphospholipid syndrome.

Praprotnik S, Agmon-Levin N, Porat-Katz BS, Blank M, Meroni PL, Cervera R, Miesbach W, Stojanovich L, Szyper-Kravitz M, Rozman B, Tomsic M, Shoenfeld Y.

Lupus. 2010 Nov;19(13):1515-9. doi: 10.1177/0961203310373781. Epub 2010 Jul 20.

PMID:
20647249
43.

Stress and autoimmunity.

Stojanovich L.

Autoimmun Rev. 2010 Mar;9(5):A271-6. doi: 10.1016/j.autrev.2009.11.014. Epub 2009 Nov 27. Review.

PMID:
19931651
44.

Neuropsychiatric lupus and association with cerebrospinal fluid immunoglobulins: a pilot study.

Stojanovich L, Smiljanich-Miljkovich D, Omdal R, Sakic B.

Isr Med Assoc J. 2009 Jun;11(6):359-62.

45.

Autonomic dysfunction in autoimmune rheumatic disease.

Stojanovich L.

Autoimmun Rev. 2009 Jun;8(7):569-72. doi: 10.1016/j.autrev.2009.01.018. Epub 2009 Feb 3. Review.

PMID:
19393212
46.

Prevalence of hepatitis C serum antibody in autoimmune diseases.

Agmon-Levin N, Ram M, Barzilai O, Porat-Katz BS, Parikman R, Selmi C, Gershwin ME, Anaya JM, Youinou P, Bizzaro N, Tincani A, Tzioufas AG, Cervera R, Stojanovich L, Martin J, Gonzalez-Gay MA, Valentini G, Blank M, SanMarco M, Rozman B, Bombardieri S, De Vita S, Shoenfeld Y.

J Autoimmun. 2009 May-Jun;32(3-4):261-6. doi: 10.1016/j.jaut.2009.02.017. Epub 2009 Apr 8.

PMID:
19356903
47.

Clinical and laboratory features of the catastrophic antiphospholipid syndrome.

Stojanovich L, Marisavljevic D, Rovensky J, Djokovich A, Kozáková D, Milinic N.

Clin Rev Allergy Immunol. 2009 Jun;36(2-3):74-9. doi: 10.1007/s12016-008-8108-8. Review.

PMID:
19052923
48.

The catastrophic antiphospholipid syndrome in Serbia: diagnostic and management problems.

Stojanovich L.

Clin Rev Allergy Immunol. 2009 Jun;36(2-3):98-103. doi: 10.1007/s12016-008-8102-1.

PMID:
19048415
49.

The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008.

Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, de Carvalho JF, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y.

Isr Med Assoc J. 2008 Jan;10(1):8-12. Review. No abstract available.

50.

Stress as a trigger of autoimmune disease.

Stojanovich L, Marisavljevich D.

Autoimmun Rev. 2008 Jan;7(3):209-13. doi: 10.1016/j.autrev.2007.11.007. Epub 2007 Nov 29. Review.

PMID:
18190880

Supplemental Content

Loading ...
Support Center